Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Change in Account Payables (2016 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Change in Account Payables for 14 consecutive years, with -$7.2 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables fell 6.07% to -$7.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.2 million through Dec 2025, up 3064.09% year-over-year, with the annual reading at $15.2 million for FY2025, 3064.09% up from the prior year.
  • Change in Account Payables hit -$7.2 million in Q4 2025 for Ani Pharmaceuticals, down from $13.8 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $13.8 million in Q3 2025 to a low of -$9.1 million in Q3 2022.
  • Historically, Change in Account Payables has averaged $1.9 million across 5 years, with a median of $2.6 million in 2021.
  • Biggest YoY gain for Change in Account Payables was 753.23% in 2022; the steepest drop was 602.32% in 2022.
  • Year by year, Change in Account Payables stood at $9.8 million in 2021, then grew by 3.02% to $10.1 million in 2022, then tumbled by 72.38% to $2.8 million in 2023, then crashed by 345.36% to -$6.8 million in 2024, then fell by 6.07% to -$7.2 million in 2025.
  • Business Quant data shows Change in Account Payables for ANIP at -$7.2 million in Q4 2025, $13.8 million in Q3 2025, and $3.1 million in Q2 2025.